Net Income (Loss) Attributable to Parent in USD of BIO-TECHNE Corp from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BIO-TECHNE Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2010 to Q3 2025.
  • BIO-TECHNE Corp Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $38.2M, a 13.6% increase year-over-year.
  • BIO-TECHNE Corp Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $78M, a 48.3% decline year-over-year.
  • BIO-TECHNE Corp annual Net Income (Loss) Attributable to Parent for 2025 was $73.4M, a 56.3% decline from 2024.
  • BIO-TECHNE Corp annual Net Income (Loss) Attributable to Parent for 2024 was $168M, a 41.1% decline from 2023.
  • BIO-TECHNE Corp annual Net Income (Loss) Attributable to Parent for 2023 was $285M, a 4.86% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $78M $38.2M +$4.59M +13.6% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $73.4M -$17.7M -$58.3M -144% 01 Apr 2025 30 Jun 2025 10-K 22 Aug 2025
Q1 2025 $132M $22.6M -$26.5M -54% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $158M $34.9M +$7.43M +27% 01 Oct 2024 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $151M $33.6M -$17.4M -34.1% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 $168M $40.6M -$34.9M -46.2% 01 Apr 2024 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 $203M $49.1M -$21.2M -30.1% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $224M $27.5M -$22.5M -45.1% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2025
Q3 2023 $247M $51M -$38.6M -43.1% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 $285M $75.5M +$14M +22.7% 01 Apr 2023 30 Jun 2023 10-K 22 Aug 2025
Q1 2023 $271M $70.2M +$9.48M +15.6% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 $262M $50M -$30.2M -37.6% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024
Q3 2022 $292M $89.6M +$19.9M +28.6% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $272M $61.5M +$46.6M +311% 01 Apr 2022 30 Jun 2022 10-K 22 Aug 2024
Q1 2022 $225M $60.7M +$15M +32.7% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 $211M $80.2M +$33.9M +73.3% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 $177M $69.6M +$36.2M +108% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $140M $15M -$43.9M -74.6% 01 Apr 2021 30 Jun 2021 10-K 23 Aug 2023
Q1 2021 $184M $45.8M +$9.35M +25.7% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $175M $46.3M -$73.3M -61.3% 01 Oct 2020 31 Dec 2020 10-Q 07 Feb 2022
Q3 2020 $248M $33.4M +$19M +132% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $229M $58.8M +$42.4M +258% 01 Apr 2020 30 Jun 2020 10-K 26 Aug 2020
Q1 2020 $187M $36.4M -$8.22M -18.4% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $195M $120M +$102M +581% 01 Oct 2019 31 Dec 2019 10-Q 08 Feb 2021
Q3 2019 $93.1M $14.4M -$3.01M -17.3% 01 Jul 2019 30 Sep 2019 10-Q 08 Feb 2021
Q2 2019 $96.1M $16.5M -$25.2M -60.5% 01 Apr 2019 30 Jun 2019 10-K 26 Aug 2020
Q1 2019 $121M $44.7M +$24.9M +126% 01 Jan 2019 31 Mar 2019 10-K 26 Aug 2020
Q4 2018 $96.4M $17.6M -$31.3M -64.1% 01 Oct 2018 31 Dec 2018 10-K 26 Aug 2020
Q3 2018 $128M $17.4M +$1.54M +9.71% 01 Jul 2018 30 Sep 2018 10-K 26 Aug 2020
Q2 2018 $126M $41.7M +$14.1M +51% 01 Apr 2018 30 Jun 2018 10-K/A 06 Nov 2019
Q1 2018 $112M $19.7M -$2.43M -11% 01 Jan 2018 31 Mar 2018 10-K/A 06 Nov 2019
Q4 2017 $114M $48.8M +$41.4M +554% 01 Oct 2017 31 Dec 2017 10-K/A 06 Nov 2019
Q3 2017 $73.1M $15.9M -$2.98M -15.8% 01 Jul 2017 30 Sep 2017 10-K/A 06 Nov 2019
Q2 2017 $76.1M $27.6M +$1.98M +7.74% 01 Apr 2017 30 Jun 2017 10-K 27 Aug 2018
Q1 2017 $74.1M $22.2M -$8.12M -26.8% 01 Jan 2017 31 Mar 2017 10-K 27 Aug 2018
Q4 2016 $82.2M $7.47M -$18.4M -71.1% 01 Oct 2016 31 Dec 2016 10-K 27 Aug 2018
Q3 2016 $101M $18.8M -$3.86M -17% 01 Jul 2016 30 Sep 2016 10-K 27 Aug 2018
Q2 2016 $104M $25.6M -$703K -2.67% 01 Apr 2016 30 Jun 2016 10-K 07 Sep 2017
Q1 2016 $105M $30.3M +$6M +24.7% 01 Jan 2016 31 Mar 2016 10-K 07 Sep 2017
Q4 2015 $99.2M $25.9M -$7.36M -22.2% 01 Oct 2015 31 Dec 2015 10-K 07 Sep 2017
Q3 2015 $107M $22.7M -$1.2M -5.02% 01 Jul 2015 30 Sep 2015 10-K 07 Sep 2017
Q2 2015 $108M $26.3M -$495K -1.85% 01 Apr 2015 30 Jun 2015 10-K 07 Sep 2017
Q1 2015 $108M $24.3M -$7.35M -23.2% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $116M $33.2M +$8.15M +32.5% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016
Q3 2014 $107M $23.9M -$3.52M -12.8% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $111M $26.8M -$1.59M -5.59% 01 Apr 2014 30 Jun 2014 10-K 29 Aug 2016
Q1 2014 $113M $31.6M -$1.48M -4.46% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $114M $25.1M -$309K -1.22% 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015
Q3 2013 $114M $27.4M +$1.76M +6.86% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 $113M $28.4M +$1.17M +4.3% 01 Apr 2013 30 Jun 2013 10-K 31 Aug 2015
Q1 2013 $111M $33.1M +$1.36M +4.29% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 $110M $25.4M -$449K -1.74% 01 Oct 2012 31 Dec 2012 10-Q 04 Feb 2014
Q3 2012 $110M $25.7M -$1.85M -6.73% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $112M $27.2M -$1.09M -3.85% 01 Apr 2012 30 Jun 2012 10-K 29 Aug 2014
Q1 2012 $113M $31.8M +$692K +2.23% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 $113M $25.8M -$721K -2.72% 01 Oct 2011 31 Dec 2011 10-Q 11 Feb 2013
Q3 2011 $113M $27.5M +$1.15M +4.35% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $112M $28.3M 01 Apr 2011 30 Jun 2011 10-K 29 Aug 2013
Q1 2011 $31.1M -$1.32M -4.09% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q4 2010 $26.5M 01 Oct 2010 31 Dec 2010 10-Q 07 Feb 2012
Q3 2010 $26.4M 01 Jul 2010 30 Sep 2010 10-Q 09 Nov 2011
Q1 2010 $32.4M 01 Jan 2010 31 Mar 2010 10-Q 10 May 2011

BIO-TECHNE Corp Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $73.4M -$94.7M -56.3% 01 Jul 2024 30 Jun 2025 10-K 22 Aug 2025
2024 $168M -$117M -41.1% 01 Jul 2023 30 Jun 2024 10-K 22 Aug 2025
2023 $285M +$13.2M +4.86% 01 Jul 2022 30 Jun 2023 10-K 22 Aug 2025
2022 $272M +$132M +93.8% 01 Jul 2021 30 Jun 2022 10-K 22 Aug 2024
2021 $140M -$88.9M -38.8% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023
2020 $229M +$133M +139% 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022
2019 $96.1M -$30.1M -23.8% 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021
2018 $126M +$50.1M +65.8% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020
2017 $76.1M -$28.4M -27.2% 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019
2016 $104M -$3.26M -3.03% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018
2015 $108M -$3.21M -2.9% 01 Jul 2014 30 Jun 2015 10-K 07 Sep 2017
2014 $111M -$1.61M -1.43% 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016
2013 $113M +$230K +0.21% 01 Jul 2012 30 Jun 2013 10-K 31 Aug 2015
2012 $112M +$29K +0.03% 01 Jul 2011 30 Jun 2012 10-K 29 Aug 2014
2011 $112M +$2.53M +2.3% 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013
2010 $110M 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.